NEPH - Nephros, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
7,414
5,687
3,809
2,320
1,944
Cost of Revenue
3,143
2,484
1,517
1,026
884
Gross Profit
4,271
3,203
2,292
1,294
1,060
Operating Expenses
Research Development
2,447
1,539
1,002
1,079
826
Selling General and Administrative
5,072
4,517
3,298
2,854
3,443
Total Operating Expenses
7,680
6,219
4,518
4,163
4,481
Operating Income or Loss
-3,409
-3,016
-2,226
-2,869
-3,421
Interest Expense
150
172
302
172
42
Total Other Income/Expenses Net
-41
-234
-74
4
375
Income Before Tax
-3,598
-3,418
-2,598
-3,032
-3,088
Income Tax Expense
-
-93
-1,789
-
-
Income from Continuing Operations
-3,505
-3,325
-809
-3,032
-3,088
Net Income
-3,505
-3,325
-809
-3,032
-3,088
Net Income available to common shareholders
-3,702
-3,402
-809
-3,032
-3,161
Reported EPS
Basic
-
-0.54
-0.18
-0.54
-0.81
Diluted
-
-0.54
-0.18
-0.54
-0.81
Weighted average shares outstanding
Basic
-
6,847
5,882
5,398
3,864
Diluted
-
6,847
5,882
5,398
3,864
EBITDA
-
-3,083
-2,078
-2,630
-2,834